Staar Surgical 

$18.95
0
+$0.49+2.65% Today

Statistics

Day High
18.96
Day Low
18.95
52W High
-
52W Low
-
Volume
2,811
Avg. Volume
-
Mkt Cap
942.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25FebExpected
Q3 2025
Next
0.18
0.24
0.29
0.34
Expected EPS
0.183333
Actual EPS
N/A

Financials

-6.44%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
627.8MRevenue
-40.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STAA.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson's vision care division competes directly with Staar Surgical in the eye health market, particularly in products related to cataract and refractive surgery.
Alcon
ALC
Mkt Cap36.88B
Alcon specializes in eye care products, including surgical devices and equipment for cataract and refractive surgery, directly competing with Staar Surgical's product offerings.
Cooper Companies
COO
Mkt Cap13.9B
The Cooper Companies operate through CooperVision, which competes in the contact lens market, and CooperSurgical, which, while more focused on women's health, has overlaps in surgical products that can compete with Staar's offerings.
Bausch Health Companies
BHC
Mkt Cap2.62B
Bausch Health Companies, through its division Bausch + Lomb, competes in the eye health sector, offering products that range from contact lenses to surgical devices, overlapping with Staar Surgical's market.
Novartis
NVS
Mkt Cap237.61B
Novartis, through its Alcon eye care division before its spin-off, was a direct competitor, and continues to have interests in the healthcare sector that indirectly compete with Staar Surgical's eye surgery products.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, after acquiring Allergan, competes in the eye care market, particularly with products for eye health and surgery, which can be seen as indirect competition to Staar Surgical's offerings.
Eco Science Solutions
ESSI
Mkt Cap26,479
EyeSys Technologies is a smaller player but competes in the corneal topography market, which is relevant for pre-surgical assessments in procedures that Staar Surgical's products are used for.

About

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Show more...
CEO
Mr. Stephen C. Farrell CFA
Employees
1157
Country
US
ISIN
US8523123052

Listings

0 Comments

Share your thoughts

FAQ

What is Staar Surgical stock price today?
The current price of STAA.BOATS is $18.95 USD — it has increased by +2.65% in the past 24 hours. Watch Staar Surgical stock price performance more closely on the chart.
What is Staar Surgical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Staar Surgical stocks are traded under the ticker STAA.BOATS.
What is Staar Surgical market cap?
Today Staar Surgical has the market capitalization of 942.61M
When is the next Staar Surgical earnings date?
Staar Surgical is going to release the next earnings report on February 25, 2026.
What were Staar Surgical earnings last quarter?
STAA.BOATS earnings for the last quarter are 0.34 USD per share, whereas the estimation was 0.25 USD resulting in a +38.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Staar Surgical revenue for the last year?
Staar Surgical revenue for the last year amounts to 627.8M USD.
What is Staar Surgical net income for the last year?
STAA.BOATS net income for the last year is -40.42M USD.
How many employees does Staar Surgical have?
As of February 02, 2026, the company has 1,157 employees.
In which sector is Staar Surgical located?
Staar Surgical operates in the Health Care sector.
When did Staar Surgical complete a stock split?
Staar Surgical has not had any recent stock splits.
Where is Staar Surgical headquartered?
Staar Surgical is headquartered in Lake Forest, US.